BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2396793)

  • 1. Comparison of pharmacokinetic variables for two injectable formulations of netobimin administered to calves.
    Lanusse CE; Ranjan S; Prichard RK
    Am J Vet Res; 1990 Sep; 51(9):1459-63. PubMed ID: 2396793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profiles of netobimin metabolites after oral administration of zwitterion and trisamine formulations of netobimin to cattle.
    Lanusse CE; Trudeau C; Ranjan S; Prichard RK
    J Vet Pharmacol Ther; 1991 Mar; 14(1):101-8. PubMed ID: 2038091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methimazole on the kinetics of netobimin metabolites in cattle.
    Lanusse CE; Prichard RK
    Xenobiotica; 1992 Jan; 22(1):115-23. PubMed ID: 1615702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the plasma concentration of albendazole sulphoxide in sheep following coadministration of parenteral netobimin and liver oxidase inhibitors.
    Lanusse CE; Prichard RK
    Res Vet Sci; 1991 Nov; 51(3):306-12. PubMed ID: 1780586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methimazole increases the plasma concentrations of the albendazole metabolites of netobimin in sheep.
    Lanusse CE; Prichard RK
    Biopharm Drug Dispos; 1992 Mar; 13(2):95-103. PubMed ID: 1550912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of albendazole metabolites following administration of albendazole, albendazole sulfoxide and netobimin to one-month- and eight-month-old sheep.
    McKellar QA; Coop RL; Jackson F
    Int J Parasitol; 1995 Oct; 25(10):1207-12. PubMed ID: 8557468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of netobimin, albendazole, and its metabolites in the pregnant rat: developmental toxicity.
    Cristòfol C; Navarro M; Franquelo C; Valladares JE; Carretero A; Ruberte J; Arboix M
    Toxicol Appl Pharmacol; 1997 May; 144(1):56-61. PubMed ID: 9169069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of netobimin metabolites in pregnant ewes.
    Cristòfol C; Franquelo C; Navarro M; Carretero A; Ruberte J; Arboix M
    Res Vet Sci; 1997; 62(2):117-20. PubMed ID: 9243708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplacental transport of netobimin metabolites in ewes.
    Cristofol C; Carretero A; Fernandez M; Navarro M; Sautet J; Ruberte J; Arboix M
    Eur J Drug Metab Pharmacokinet; 1995; 20(3):167-71. PubMed ID: 8751036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal distribution of albendazole metabolites following netobimin administration to cattle: relationship with plasma disposition kinetics.
    Lanusse CE; Gascon LH; Prichard RK
    J Vet Pharmacol Ther; 1993 Mar; 16(1):38-47. PubMed ID: 8478999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methimazole-mediated modulation of netobimin biotransformation in sheep: a pharmacokinetic assessment.
    Lanusse CE; Gascon L; Prichard RK
    J Vet Pharmacol Ther; 1992 Sep; 15(3):267-74. PubMed ID: 1433490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma profiles of albendazole metabolites after administration of netobimin and albendazole in sheep: effects of parasitism and age.
    McKellar QA; Jackson F; Coop RL; Baggot JD
    Br Vet J; 1993; 149(1):101-13. PubMed ID: 8439796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of albendazole sulphoxide after netobimin administration in sheep: effects of fenbendazole coadministration.
    Merino G; Alvarez AI; Redondo PA; Garcia JL; Larrodé OM; Prieto JG
    Res Vet Sci; 1999 Jun; 66(3):281-3. PubMed ID: 10333473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ricobendazole kinetics and availability following subcutaneous administration of a novel injectable formulation to calves.
    Lanusse CE; Virkel GL; Sanchez SF; Alvarez LI; Lifschitz AL; Imperiale F; Monfrinotti A
    Res Vet Sci; 1998; 65(1):5-10. PubMed ID: 9769065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic behaviour of netobimin and its metabolites in sheep.
    Lanusse CE; Prichard RK
    J Vet Pharmacol Ther; 1990 Jun; 13(2):170-8. PubMed ID: 2384908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of albendazole, albendazole sulfoxide and netobimin in goats.
    Benchaoui HA; Scott EW; McKellar QA
    J Vet Pharmacol Ther; 1993 Jun; 16(2):237-40. PubMed ID: 8345574
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative pharmacokinetics of netobimin and albendazole in the one-humped camel (Camelus dromedarius).
    Delatour P; Ouhsine A; Benoit E
    Br Vet J; 1989; 145(5):478-82. PubMed ID: 2790441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and tissue fluid norfloxacin concentrations after oral administration of the drug to healthy dogs.
    Walker RD; Stein GE; Budsberg SC; Rosser EJ; MacDonald KH
    Am J Vet Res; 1989 Jan; 50(1):154-7. PubMed ID: 2919820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioconversion of netobimin pro-drug by gastrointestinal fluids of ruminants.
    Lanusse CE; Nare B; Gascon LH; Prichard RK
    Eur J Drug Metab Pharmacokinet; 1992; 17(2):121-8. PubMed ID: 1425810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.